Best Healthcare Companies in Guangdong Province, China
The 113 best Healthcare companies in Guangdong Province, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: DistinctClinic.
Ranked: Best Healthcare companies in Guangdong Province
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | DistinctClinic Chain of general clinics | $168M | 57 mo ago | Public | 36 | 2012 | — | 2 partnerships · 2 expansions |
| 2 | Zhuhai Hokai Medical Instruments Provider of building design and construction services | $150M | 130 mo ago | Late Stage | 760 | 1996 | Zhen Xi Hao CEO & President | — |
| 3 | Xbiome Developer of an AI-enabled bioinformatics platform for the discovery of drugs using intestinal microbiome 64AI top 20%Funding top 36%Moat top 38%Market top 49% All 5 signals ▾AItop 20% Fundingtop 36% Moattop 38% Markettop 49% Globalbottom 36% AI: Classified as an AI company Funding: Raised $108M across 2 rounds · 2 rounds over 8 yrs (0.2/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $108M | 53 mo ago | Series B | 63 | 2017 | — | — |
| 4 | HwaGen Pharma CDMO focused on manufacturing of APIs | $100M | 58 mo ago | Series B | 500 | 2015 | — | — |
| 5 | Yimai Sunshine Imaging Hospital Group Operator of medical imaging centers providing diagnostic and related healthcare services | $83M | 83 mo ago | Public | 970 | 2014 | — | — |
| 6 | Readline R&D company manufacturing and exporting cosmetic, drug, and amino acid peptides | $74M | 15 mo ago | Series C | 300 | 2013 | Jian Liu Co-Founder | — |
| 7 | Trinomab Developer of immunotherapeutics for multiple diseases | $69M | 61 mo ago | Series A | 48 | 2015 | Zheng Weihong CEO | — |
| 8 | Ruiguang Kangtai Technology Manufacturer of blood pressure measurement and laser therapy devices | $56M | 69 mo ago | Series B | — | 2008 | — | — |
| 9 | Global Pharm Holdings Developer and manufacturer of herbal medicines | $47M | 175 mo ago | Series C | 500 | 2007 | Yunlu Yin Chairman & CEO | — |
| 10 | Zhuhai Ruisi Puli Bio-Pharmaceutical Manufacturer of generic drugs & biological antibodies and equipment | $38M | 64 mo ago | Series B | — | 2018 | Cambridge Haigui Founder | — |
| 11 | Shankang Medical R&D based manufacturer of drugs for multiple therapeutics | $28M | 57 mo ago | Series B | 127 | 2017 | — | — |
| 12 | Rezubio Manufacturer of generic drugs | $20M | 6 mo ago | Series A | 5 | 2019 | Yusheng Xiong CEO | — |
| 13 | Belter Devices for personal health monitoring | $18M | 139 mo ago | Series C | — | 2008 | — | — |
| 14 | Shenzhen Qianhai Xiaozao Technology Offers microbial expression systems-based biologics development and manufacturing services | $16M | 61 mo ago | Series B | 130 | 2016 | — | 1 launch |
| 15 | Shenzhen Weigong Technology Manufacturer of flow cytometer, sampling tray, lysing, and other lab tools | $15M | 59 mo ago | Series B | — | 2016 | Li Weigong Founder | — |
| 16 | Hybio Pharmaceutical Developer and manufacturer of polypeptide drugs and APis | $15M | 219 mo ago | Public | 975 | 1998 | Jiancheng Yuan CEO & President | — |
| 17 | Quiknos Solution for laboratory test management | $15M | 95 mo ago | Series B | — | 2015 | Charles Wang Co-Founder | — |
| 18 | Sailu Medical Provider of upstream sequencing platforms development services | $14M | 44 mo ago | Seed | — | 2020 | — | — |
| 19 | Shenzhen Yihe Health Management Standalone gynecology clinic | $7M | 57 mo ago | Series A | — | 2016 | Pei Honggang Founder | — |
| 20 | Hochuen Medical Manufacturer of medical disposables & devices, and wearable medical products | $6M | 40 mo ago | Series B | 19 | 2016 | Robin Liu Co-Founder | — |
| 21 | APK Technology Manufacturer of medical cables, sensors, and related consumables | $3M | 159 mo ago | Funding Raised | — | 2003 | Rao Xiaomao CEO | 1 partnership |
| 22 | Shenzhen Boen Clinical Standalone general clinic | $1M | 86 mo ago | Seed | 60 | 2017 | — | — |
| 23 | Medcaptain Manufacturer of medical devices including patient monitoring and diagnostic equipment | $206K | 76 mo ago | Funding Raised | 126 | 2011 | Jie Liu Co-Founder & CEO | 2 launchs |
Top 12 Healthcare companies in Guangdong Province
#1
Series A · Zhuhai, Guangdong Province · founded 2019 · 5 employees$20Mraised▾
Manufacturer of generic drugs
- Dec 2025Series A$20M
- Feb 2023Seed—
#2
Series C · Shenzhen, Guangdong Province · founded 2013 · 300 employees$74.3Mraised▾
R&D company manufacturing and exporting cosmetic, drug, and amino acid peptides
- Feb 2025Series C$68.9M
- Dec 2022Series B$43M
- Nov 2021Series A$31.3M
#3
Public · Shenzhen, Guangdong Province · founded 2012 · 36 employees$167.5Mraised▾
Chain of general clinics
- Sep 2021Series E$60M
- 2019Series D$50M
- Aug 2017Series C$40M
- Apr 2015Series B$17.5M
#4
Series B · Shenzhen, Guangdong Province · founded 2017 · 63 employees$107.5Mraised▾
Developer of an AI-enabled bioinformatics platform for the discovery of drugs using intestinal microbiome. The company uses Fecal microbiota transplantation (FMT) technology for the development of drugs for multiple diseases. It includes extraction of microbiota from the stool of healthy people through various methods and then transplant it into patients and used to treat various diseases.
- Dec 2021Series B$100M
- Dec 2020Series B—
- Nov 2019Series B—
- Jun 2019Series A—
#5
Series B · Shenzhen, Guangdong Province · founded 2015 · 500 employees$100Mraised▾
CDMO focused on manufacturing of APIs
- Aug 2021Series B$100M
#6
Series A · Zhuhai, Guangdong Province · founded 2015 · 48 employees$69.3Mraised▾
Developer of immunotherapeutics for multiple diseases
- Apr 2021Series A$69.3M
#7
Late Stage · Zhuhai, Guangdong Province · founded 1996 · 760 employees$149.9Mraised▾
Provider of building design and construction services. This company offers a variety of services, including architectural design, structural engineering, and project management. They handle all aspects of the building process, from initial concept to final completion. Services encompass various building types and scales, focusing on efficient and effective project delivery. Their expertise includes design and build solutions, ensuring seamless integration of design and construction phases. They also provide building maintenance and renovation services.
- Jul 2015Post IPO$149.9M
#8
Public · Shenzhen, Guangdong Province · founded 2014 · 970 employees$82.9Mraised▾
Operator of medical imaging centers providing diagnostic and related healthcare services. The organization focuses on delivering imaging services through a network of facilities. Core services encompass imaging center operations, solutions for medical imaging, and cloud-based services. It also conducts research and development in relevant areas and offers specialized services.
- Jul 2019Series C—
- Sep 2018Series B$18.9M
- Feb 2018Series B$64M
- 2016Series A—
#9
Series B · Shenzhen, Guangdong Province · founded 2008$56.5Mraised▾
Manufacturer of blood pressure measurement and laser therapy devices
#10
Seed · Shenzhen, Guangdong Province · founded 2020$13.9Mraised▾
Provider of upstream sequencing platforms development services
#11
Series B · Zhuhai, Guangdong Province · founded 2018$37.9Mraised▾
Developer of inhaled formulations and pulmonary drug delivery technology for respiratory disease. The company focuses on the research and development of treatments for Asthma, COPD (Chronic Obstructive Pulmonary Disease), diabetes, and Parkinson's Disease.
- Feb 2021Series B$30.9M
- Aug 2019Series A$7M
#12
Series B · Shenzhen, Guangdong Province · founded 2017 · 127 employees$28.3Mraised▾
Developer of addiction treatment drugs intended to prevent opioid drug users from relapse. The company focuses on the core technology of sustained and controlled drug addiction treatment, and the naltrexone sustained-release agent developed has completed phase II clinical trials. Naltrexone is the only opioid anti-relapse drug recommended by WHO. The company has developed naltrexone sustained-release agent through subcutaneous implantation to release the drug slowly and evenly, effectively solving the industry's pain points of relapse of opioids.
- Aug 2021Series B$28.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.